GLYZIAMET XR TABLET 100:1000 Price in Pakistan

View latest Price, manufacturer, formulation, and pack details of GLYZIAMET XR TABLET 100:1000.

Available Products of GLYZIAMET XR TABLET 100:1000

GLYZIAMET XR TABLET 100:1000 10's

Reg#: 092859

Description of GLYZIAMET XR TABLET 100:1000

Each modified release film coated tablet contains Sitagliptin 100 mgMetformin HCl 1000 mg

Medicine Info

Pack Size: 10's

Company: AGP LIMITED

Price of GLYZIAMET XR TABLET 100:1000

Price: Rs. 1354.61

Related Keywords

  • GLYZIAMET XR TABLET 100:1000 price in Pakistan
  • GLYZIAMET XR TABLET 100:1000 tablet price
  • GLYZIAMET XR TABLET 100:1000 Capsule price
  • AGP LIMITED GLYZIAMET XR TABLET 100:1000 price
  • Buy GLYZIAMET XR TABLET 100:1000 online
  • GLYZIAMET XR TABLET 100:1000 uses
  • GLYZIAMET XR TABLET 100:1000 syrup price
  • GLYZIAMET XR TABLET 100:1000 pack 10's cost

GLYZIAMET XR TABLET 100:1000 14's

Reg#: 092859

Description of GLYZIAMET XR TABLET 100:1000

Each modified release film coated tablet contains Sitagliptin 100mgMetformin HCl 1000 mg

Medicine Info

Pack Size: 14's

Company: AGP LIMITED

Price of GLYZIAMET XR TABLET 100:1000

Price: Rs. 1897.22

Related Keywords

  • GLYZIAMET XR TABLET 100:1000 price in Pakistan
  • GLYZIAMET XR TABLET 100:1000 tablet price
  • GLYZIAMET XR TABLET 100:1000 Capsule price
  • AGP LIMITED GLYZIAMET XR TABLET 100:1000 price
  • Buy GLYZIAMET XR TABLET 100:1000 online
  • GLYZIAMET XR TABLET 100:1000 100mgmetformin uses
  • GLYZIAMET XR TABLET 100:1000 syrup price
  • GLYZIAMET XR TABLET 100:1000 pack 14's cost

Alternatives brands of GLYZIAMET XR TABLET 100:1000

Explore alternative brands for GLYZIAMET XR TABLET 100:1000 below.

View Alternatives

Explore More Medicines

INAPEL 0.1% CREAM

AGP LIMITED

MRP: Rs. 283.9800

INAPEL 0.1% CREAM

AGP LIMITED

MRP: Rs. 750.5040

INAPEL 0.1% GEL

AGP LIMITED

MRP: Rs. 283.9800

INAPEL 0.3% GEL

AGP LIMITED

MRP: Rs. 649.0920

INAPEL 0.3% GEL

AGP LIMITED

MRP: Rs. 1460.4480

We’d love to hear your thoughts!

Share your comment below and join the conversation ✨

Comments

No comments yet. Be the first!